Demand for orthopedic implants will remain under pressure until the economy improves and consumers have insurance again, Zimmer Holdings Chief Executive David Dvorak said at the J.P. Morgan Healthcare Conference in San Francisco. "There will continue to be an impact until unemployment rates are reduced and (insurance) enrollment rates go back up," Dvorak told investors in a presentation webcast. Report